Dr. Ian Corbin (left) and Dr. Xiaodong Wen look over lab samples from their study of an experimental nanoparticle therapy that shows promise for fighting primary liver cancer. Credit: UT Southwestern Medical Center
“This approach offers a potentially new and safe way of treating liver cancer, and possibly other cancers,” said study Assistant Professor/ Dr. Ian Corbin . “The method utilizes the cholesterol carrier LDL, combined with fish oil to produce a unique nanoparticle that is selectively toxic to cancer cells.”
Primary liver cancer, or hepatocellular carcinoma, is the 6th most prevalent type of cancer and 3rd-leading cause of cancer-related deaths worldwide. Incidence of the disease is rising in the US, principally in relation to the spread of hepatitis C.
Fish oils are particularly r...
Read More
Recent Comments